These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 26573206)
1. Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology. Perez-Alamino R; Maldonado-Ficco H; Maldonado-Cocco JA Clin Rheumatol; 2016 Feb; 35(2):291-6. PubMed ID: 26573206 [TBL] [Abstract][Full Text] [Related]
4. Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis. Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Rizzello F; Gionchetti P J Rheumatol; 2017 Sep; 44(9):1341-1346. PubMed ID: 28412702 [TBL] [Abstract][Full Text] [Related]
5. Rheumatic manifestations of inflammatory bowel disease. Rodríguez-Reyna TS; Martínez-Reyes C; Yamamoto-Furusho JK World J Gastroenterol; 2009 Nov; 15(44):5517-24. PubMed ID: 19938189 [TBL] [Abstract][Full Text] [Related]
6. The Joint-Gut Axis Exploring the Orthopaedic and Rheumatologic Manifestations of Inflammatory Bowel Disease. Gaspar MP; Gaspar JP; Kane PM Bull Hosp Jt Dis (2013); 2016 Sep; 74(3):185-92. PubMed ID: 27620540 [TBL] [Abstract][Full Text] [Related]
7. Musculoskeletal manifestations in a Portuguese cohort of 235 inflammatory bowel disease patients. Fernandes BM; Rosa-Gonçalves D; Magro F; Costa L; Bernardes M ARP Rheumatol; 2022; 1(2):137-141. PubMed ID: 35810372 [TBL] [Abstract][Full Text] [Related]
8. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Turkcapar N; Toruner M; Soykan I; Aydintug OT; Cetinkaya H; Duzgun N; Ozden A; Duman M Rheumatol Int; 2006 May; 26(7):663-8. PubMed ID: 16136311 [TBL] [Abstract][Full Text] [Related]
9. Rheumatic complications of inflammatory bowel disease among Arabs: a hospital-based study in Kuwait. Al-Jarallah K; Shehab D; Al-Azmi W; Al-Fadli A Int J Rheum Dis; 2013 Apr; 16(2):134-8. PubMed ID: 23773636 [TBL] [Abstract][Full Text] [Related]
10. Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors. Subramaniam K; Tymms K; Shadbolt B; Pavli P Intern Med J; 2015 Nov; 45(11):1154-60. PubMed ID: 26337851 [TBL] [Abstract][Full Text] [Related]
11. Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients. Conigliaro P; Chimenti MS; Ascolani M; Triggianese P; Novelli L; Onali S; Lolli E; Calabrese E; Petruzziello C; Pallone F; Perricone R; Biancone L Autoimmun Rev; 2016 Feb; 15(2):184-90. PubMed ID: 26554932 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease. Stolwijk C; Pierik M; Landewé R; Masclee A; van Tubergen A Can J Gastroenterol; 2013 Apr; 27(4):199-205. PubMed ID: 23616957 [TBL] [Abstract][Full Text] [Related]
13. The joint-gut axis in inflammatory bowel diseases. Brakenhoff LK; van der Heijde DM; Hommes DW; Huizinga TW; Fidder HH J Crohns Colitis; 2010 Sep; 4(3):257-68. PubMed ID: 21122514 [TBL] [Abstract][Full Text] [Related]
14. Occult spondyloarthritis in inflammatory bowel disease. Bandinelli F; Manetti M; Ibba-Manneschi L Clin Rheumatol; 2016 Feb; 35(2):281-9. PubMed ID: 26354428 [TBL] [Abstract][Full Text] [Related]
15. [Prevalence of axial manifestations among patients with inflammatory bowel disease: a prospective study about 50 cases]. Saadallaoui Ben Hamida K; Dougui MH; Ksontini I; Ben Yaghéléne L; Bouhaouala MH Tunis Med; 2009 Jun; 87(6):386-90. PubMed ID: 19927784 [TBL] [Abstract][Full Text] [Related]